Neutrophil gelatinase-associated lipocalin
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 22: | Line 22: | ||
*Neutrophil gelatinase-associated lipocalin | *Neutrophil gelatinase-associated lipocalin | ||
| - | **[[1dfv]], [[1qqs]], [[ | + | **[[1dfv]], [[1qqs]], [[3bx8]], [[6gqz]], [[6z6z]] – hNGAL – human <br /> |
**[[3dtq]], [[5jr8]], [[5mhh]], [[6o5d]], [[6qmu]] – hNGAL (mutant)<br /> | **[[3dtq]], [[5jr8]], [[5mhh]], [[6o5d]], [[6qmu]] – hNGAL (mutant)<br /> | ||
**[[1ngl]] – hNGAL - NMR<br /> | **[[1ngl]] – hNGAL - NMR<br /> | ||
| Line 51: | Line 51: | ||
**[[4qae]] – hNGAL (mutant) + hepcidin<br /> | **[[4qae]] – hNGAL (mutant) + hepcidin<br /> | ||
**[[3bx7]] – hNGAL + CTLA-4<br /> | **[[3bx7]] – hNGAL + CTLA-4<br /> | ||
| + | **[[6z2c]] – hNGAL + transition state analog<br /> | ||
**[[4mvi]], [[4mvk]], [[4mvl]] – hNGAL (mutant) + beta-APP40<br /> | **[[4mvi]], [[4mvk]], [[4mvl]] – hNGAL (mutant) + beta-APP40<br /> | ||
| + | **[[6s8v]] – hNGAL + h4F2HC<br /> | ||
| + | **[[6sua]] – hNGAL (mutant) + m4F2HC<br /> | ||
**[[3u9p]] – mNGAL + antibody<br /> | **[[3u9p]] – mNGAL + antibody<br /> | ||
Current revision
| |||||||||||
3D structures of neutrophil gelatinase-associated lipocalin
Updated on 16-July-2023
References
- ↑ Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J. 1999 Jul;31(7):433-41. PMID:10475571
- ↑ Dartt DA. Tear lipocalin: structure and function. Ocul Surf. 2011 Jul;9(3):126-38. PMID:21791187
- ↑ Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, Friedlander G, Barasch J, Terzi F. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest. 2010 Nov;120(11):4065-76. doi: 10.1172/JCI42004. PMID:20921623 doi:http://dx.doi.org/10.1172/JCI42004
- ↑ Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005 Jan;13(1):29-41. PMID:15642259 doi:10.1016/j.str.2004.10.009
